Biomaterials-Based Modulation of the Immune System
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The immune system is traditionally considered from the perspective of defending against bacterial or viral infections. However, foreign materials like implants can also illicit immune responses. These immune responses are mediated by a large number of molecular signals, including cytokines, antibodies and reactive radical species, and cell types, including macrophages, neutrophils, natural killer cells, T-cells, B-cells, and dendritic cells. Most often, these molecular signals lead to the generation of fibrous encapsulation of the biomaterials, thereby shielding the body from these biomaterials. In this review we will focus on two different types of biomaterials: those that actively modulate the immune response, as seen in antigen delivery vehicles for vaccines, and those that illicit relatively small immune response, which are important for implantable materials. The first serves to actively influence the immune response by co-opting certain immune pathways, while the second tries to mimic the properties of the host in an attempt to remain undetected by the immune system. As these are two very different end points, each type of biomaterial has been studied and developed separately and in recent years, many advances have been made in each respective area, which will be highlighted in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These infiltrating host cells, such as neutrophils, macrophages, lymphocytes, and stromal cells, continuously secrete matrix metalloproteinases (MMPs), which catalyze the ECM components of the scaffolds11,16.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upon transplantation, inflammatory responses are strongly linked to the MMP-mediated degradation of the scaffolds.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Produced bioactive matricryptins not only stimulate systemic inflammation after being engulfed by phagocytes but also accelerate chemotaxis toward the transplants11,16.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As xenograft-derived dECM scaffolds are recognized as foreign bodies by the host immune system, immune cells infiltrate into the transplants and release proteases to degrade the scaffolds14,16.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Bioactive glass in tissue engineering
Rahaman, M. N., Day, D. E., Sonny Bal, B., Fu, Q., Jung, S. B., Bonewald, L. F., & Tomsia, A. P. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.03.016 · Cited by 1,794
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Topographical control of cells
Curtis, A., & Wilkinson, C. (1997) · Biomaterials · doi:10.1016/s0142-9612(97)00144-0 · Cited by 1,405
Reducing implant-related infections: active release strategies
Hetrick, E. M., & Schoenfisch, M. H. (2006) · Chemical Society Reviews · doi:10.1039/b515219b · Cited by 1,201
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050 · cited 1×
“By varying the length of the chains, it was observed that shorter chains (2000 g/mol) were able to penetrate well, while longer chains (10000 g/mol) penetrated at a significantly reduced rate [24].”
BackgroundPEG-SS-PPS: Reduction-Sensitive Disulfide Block Copolymer Vesicles for Intracellular Drug Delivery
Cerritelli, S., Velluto, D., & Hubbell, J. A. (2007) · Biomacromolecules · doi:10.1021/bm070085x · Cited by 443
Polyhydroxyalkanoate (PHA)/Inorganic Phase Composites for Tissue Engineering Applications
Misra, S. K., Valappil, S. P., Roy, I., & Boccaccini, A. R. (2006) · Biomacromolecules · doi:10.1021/bm060317c · Cited by 372
Wang, Y.-X., Robertson, J. L., Spillman, W. B., & Claus, R. O. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036909.41843.18 · Cited by 357
Wennerberg, A. (1996) · Biomaterials · doi:10.1016/0142-9612(96)80750-2 · Cited by 355
Poly(vinyl alcohol) as versatile biomaterial for potential biomedical applications
Paradossi, G., Cavalieri, F., Chiessi, E., Spagnoli, C., & Cowman, M. K. (2003) · Journal of Materials Science: Materials in Medicine · doi:10.1023/a:1024907615244 · Cited by 334
Molecular aspects of muco- and bioadhesion:
Huang, Y., Leobandung, W., Foss, A., & Peppas, N. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00233-3 · Cited by 316
Hu, Y., Litwin, T., Nagaraja, A. R., Kwong, B., Katz, J., Watson, N., & Irvine, D. J. (2007) · Nano Letters · doi:10.1021/nl071542i · Cited by 305
Platelet interactions with titanium: modulation of platelet activity by surface topography
Park, J. Y., Gemmell, C. H., & Davies, J. E. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00009-6 · Cited by 297
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines
Wang, C., Ge, Q., Ting, D., Nguyen, D., Shen, H.-R., Chen, J., Eisen, H. N., Heller, J., Langer, R., & Putnam, D. (2004) · Nature Materials · doi:10.1038/nmat1075 · Cited by 262
In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films
Draye, J.-P., Delaey, B., Van de Voorde, A., Van Den Bulcke, A., De Reu, B., & Schacht, E. (1998) · Biomaterials · doi:10.1016/s0142-9612(98)00049-0 · Cited by 258
The Pathophysiology and Burden of Restenosis
Weintraub, W. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.002 · Cited by 229
Giant cell formation and function
Brodbeck, W. G., & Anderson, J. M. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac52e · Cited by 223
Cruz, L. J., Tacken, P. J., Fokkink, R., & Figdor, C. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.082 · Cited by 201
Mediators of the inflammatory response to joint replacement devices
Cobelli, N., Scharf, B., Crisi, G. M., Hardin, J., & Santambrogio, L. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.128 · Cited by 196
Hyaluronate Derivatives in Drug Delivery
Vercruysse, K. P., & Prestwich, G. D. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.30 · Cited by 190
Fully Acid-Degradable Biocompatible Polyacetal Microparticles for Drug Delivery
Paramonov, S. E., Bachelder, E. M., Beaudette, T. T., Standley, S. M., Lee, C. C., Dashe, J., & Fréchet, J. M. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004472 · Cited by 178
Inhibition of implant-associated infections via nitric oxide release
Nablo, B. J., Prichard, H. L., Butler, R. D., Klitzman, B., & Schoenfisch, M. H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.017 · Cited by 176
Polymeric Chitosan-based Vesicles for Drug Delivery
Uchegbu, I. F., Schätzlein, A. G., Tetley, L., Gray, A. I., Sludden, J., Siddique, S., & Mosha, E. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06185.x · Cited by 137
Protein release from collagen matrices
Fujioka, K. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00119-1 · Cited by 129
Chemistry and biocompatibility of alginate‐PLL capsules for immunoprotection of mammalian cells
de Vos, P., van Hoogmoed, C. G., & Busscher, H. J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10060 · Cited by 121
Espadas-Torre, C., & Meyerhoff, M. E. (1995) · Analytical Chemistry · doi:10.1021/ac00114a003 · Cited by 117
Microparticle surface modifications targeting dendritic cells for non-activating applications
Lewis, J. S., Zaveri, T. D., Crooks, C. P., & Keselowsky, B. G. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.049 · Cited by 97
Flanary, S., Hoffman, A. S., & Stayton, P. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800317a · Cited by 86
Adhesive substrate-modulation of adaptive immune responses
Acharya, A. P., Dolgova, N. V., Clare-Salzler, M. J., & Keselowsky, B. G. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.040 · Cited by 86
Self-citationAcharya, A. P., Dolgova, N. V., Moore, N. M., Xia, C., Clare-Salzler, M. J., Becker, M. L., Gallant, N. D., & Keselowsky, B. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.025 · Cited by 75
Self-citationHu, Y., Atukorale, P. U., Lu, J. J., Moon, J. J., Um, S. H., Cho, E. C., Wang, Y., Chen, J., & Irvine, D. J. (2009) · Biomacromolecules · doi:10.1021/bm801199z · Cited by 73
Heffernan, M. J., Kasturi, S. P., Yang, S. C., Pulendran, B., & Murthy, N. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.034 · Cited by 73
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines
Acharya, A. P., Clare-Salzler, M. J., & Keselowsky, B. G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.032 · Cited by 59
Self-citationEnhanced Cell Penetration of Acid-Degradable Particles Functionalized with Cell-Penetrating Peptides
Cohen, J. L., Almutairi, A., Cohen, J. A., Bernstein, M., Brody, S. L., Schuster, D. P., & Fréchet, J. M. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700414j · Cited by 49
Surface structural conformations of fibrinogen polypeptides for improved biocompatibility
Yaseen, M., Zhao, X., Freund, A., Seifalian, A. M., & Lu, J. R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.107 · Cited by 48
Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles
Acharya, A. P., Lewis, J. S., & Keselowsky, B. G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.032 · Cited by 32
Self-citationAcharya, A. P., Dolgova, N. V., Xia, C. Q., Clare-Salzler, M. J., & Keselowsky, B. G. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.08.026 · Cited by 31
Self-citationChoe, S., Acharya, A. P., Keselowsky, B. G., & Sorg, B. S. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.03.006 · Cited by 24
Self-citation
Research works printed but not linked: 1
- 1998, Critical Reviews in Therapeutic Drug Carrier Systems, 15, 513
Cited by
Biomaterial based modulation of macrophage polarization: a review and suggested design principles
Sridharan, R., Cameron, A. R., Kelly, D. J., Kearney, C. J., & O’Brien, F. J. (2015) · Materials Today · doi:10.1016/j.mattod.2015.01.019 · Cited by 826
“Upon surgical implantation, it has been shown that the initial M1 response is responsible for recruiting inflammatory cells to the site of injury and for instigating the ensuing foreign body response [5,86,91], which are necessary events for wound healing.”
BackgroundMacrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
Antibacterial Surface Treatment for Orthopaedic Implants
Gallo, J., Holinka, M., & Moucha, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813849 · Cited by 344
Romanò, C. L., Scarponi, S., Gallazzi, E., Romanò, D., & Drago, L. (2015) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-015-0294-5 · Cited by 311
Du, Y., Liu, X., Liang, Q., Liang, X.-J., & Tian, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00630 · Cited by 260
Metadata
- Authors
- Gardner, A. B., Lee, S. K. C., Woods, E. C., & Acharya, A. P.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Acharya, Abhinav P.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-7
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC3793288
- OpenAlex
- W2138876059
- Cited by
- 81
- References
- 41
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 3 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 6 · 2017: 3 · 2016: 13 · 2015: 7 · 2014: 4
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
- Keywords
- biomaterials, immunomodulation, implant biocompatibility, vaccine adjuvants, fibrous encapsulation, immune evasion, cytokines, reactive oxygen species, macrophages, dendritic cells, implant materials
- MeSH terms
- Animals, Biocompatible Materials, Dendritic Cells, Humans, Immunologic Factors, Leukocytes, Drug Delivery Systems, Prostheses and Implants
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.